๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Schizophrenia
Clinical trial register · China

Schizophrenia Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Changsha 10 Beijing 8 Shanghai 8 Tianjin 4 Zhumadian 2
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Shanghai Mental Health Center8 Central South University7 China Medical University Hospital7 Luye Pharma Group Ltd.3 Vigonvita Life Sciences3
Site location
Changsha10 Beijing8 Shanghai8 Tianjin4 Zhumadian2
All 22 locations
Target enrolment
to

Schizophrenia trials in China

44 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Improving Quality of Informal Care for People With Schizophrenia
NCT07781748Schizophrenia
Chinese University of Hong Kong
Not applicable
228
Chengdu
2027-07-01
Not yet open
Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical Applications
NCT07444463Schizophrenia, Bipolar Disorder, Major Depressive Disorder (MDD)
Central South University
Not applicable
400
Changsha
2027-01-01
Not yet open
Xingqi Daozhi Decoction for Antipsychotic-Induced Constipation
NCT07767526Schizophrenia, Antipsychotic Drug
Shanghai Mental Health Center
Phase 1/2
46
Shanghai
2026-10-01
Not yet open
The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain
NCT07795554Schizophrenia Spectrum, Schizophrenia, Antipsychotic Induced Weight Gain
Second Xiangya Hospital of Central South University
Not applicable
60
Changsha
2026-09-01
Not yet open
A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia
NCT07805980Schizophrenia, Antipsychotic Induced Weight Gain
Second Xiangya Hospital of Central South University
Not applicable
30
Changsha
2026-09-01
Not yet open
Evaluating Safety and Efficacy of VV119 in Acute Schizophrenia Adults
NCT07703956Schizophrenia
DrugsVV119·Aripiprazole
Vigonvita Life Sciences
Phase 2
500
Beijing
2026-07-31
Recruiting
tACS for Working Memory in Schizophrenia
NCT07701343Schizophrenia, Working Memory
Central South University
Not applicable
30
Changsha
2026-07-06
Not yet open
Transcranial Sonography and Machine Learning for Schizophrenia Identification
NCT07604129Schizophrenia
Taizhou Second People's Hospital
Observational
200
Taizhou
2026-06-15
Recruiting
A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse
NCT07616999Schizophrenia
The University of Hong Kong
Observational
178
Hong Kong
2026-05-21
Recruiting
The Effect of Game-Based Intervention on the Cognition of Schizophrenia Patients
NCT07557381Schizophrenia
Shanghai Mental Health Center
Not applicable
84
Shanghai
2026-04-19
Recruiting
Effects of Gamified Rehabilitation on Cognitive and Psychosocial Outcomes in Inpatients With Schizophrenia
NCT07557368Schizophrenia
Shanghai Mental Health Center
Not applicable
84
Shanghai
2026-04-19
Not yet open
A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia
NCT07396870Schizophrenia
DrugLY03020
Luye Pharma Group Ltd.
Phase 2
160
Beijing
2026-03-31
Recruiting
A Study of Brenipatide in Adult Participants With Schizophrenia
NCT07410507Schizophrenia
DrugBrenipatide
Eli Lilly and Company
Phase 2
450
Changsha, Chengdu, Hangzhou, Suzhou, Tianjin, Wuhu, Xi'an, Zhumadian
2026-02-10
Recruiting
Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders
NCT07479758Major Depressive Disorder (MDD), Schizophrenia, Bipolar Disorder, Severe Mental Disorders
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
320
Hangzhou
2025-11-01
Recruiting
Personalized iTBS in Real-World Clinical Settings for Schizophrenia
NCT07176468Schizophrenia, Transcranial Magnetic Stimulation
Anhui Medical University
Not applicable
40
Hefei
2025-10-20
Not yet open
Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia
NCT07075237Schizophrenia
Jiangsu Province Nanjing Brain Hospital
Phase 4
120
Nanjing
2025-10
Recruiting
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
NCT07122895Schizophrenia
DrugNmdae
China Medical University Hospital
Phase 2
90
2025-09-16
Recruiting
A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020
NCT07230652Schizophrenia, Alzheimer's Disease Psychosis
Luye Pharma Group Ltd.
Phase 1
40
Beijing
2025-08-20
Active, closed
A Food Effect Study of LY03020 in Healthy Subjects
NCT07292233Schizophrenia, Alzheimer's Disease Psychosis
DrugLY03020
Luye Pharma Group Ltd.
Phase 1
16
Beijing
2025-07-30
Recruiting
Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients
NCT07045142Schizophrenia
DrugsAtorvastatin·Metformin
Central South University
Phase 3
400
Zhumadian, Changsha, Yueyang, Dali, Xiangshan
2025-07-01
Recruiting
RTMS for Refractory Auditory Hallucinations Based on Personalized Targets Using Magnetoencephalography
NCT06802939Refractory Auditory Hallucinations, Schizophrenia
Shanghai Mental Health Center
Not applicable
36
Shanghai
2025-02-05
Recruiting
Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in Schizophrenia
NCT06673966Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, Mental Disorders
Central South University
Observational
200
Changsha
2025-01-10
Recruiting
nTMS for Negative Symptom in Schizophrenia
NCT06642675Schizophrenia
Central South University
Not applicable
40
Changsha
2024-11-22
Recruiting
A Bioequivalence Study of PP3M in Patients With Schizophrenia
NCT07493551Schizophrenia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Not applicable
260
Beijing
2024-10-09
Recruiting
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
NCT06574360Schizophrenia
DrugNmdae
China Medical University Hospital
Phase 2
90
2024-09-23
Recruiting
A Study on the Preference of Risperidone Dosage Forms
NCT06657430Schizophrenia, Bipolar Affective Disorder, Autism Spectrum Disorder, Conduct Disorder
Shanghai Mental Health Center
Observational
1,000
Shanghai
2024-09-19
Recruiting
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
NCT06504290Schizophrenia
DrugVV119
Vigonvita Life Sciences
Phase 1
40
Beijing, Xiโ€™an
2024-07-16
Recruiting
The Hi-tACS on Cognitive Function in Patients With Schizophrenia
NCT06470516Schizophrenia
Sir Run Run Shaw Hospital
Not applicable
100
Hanzhou, Quzhou
2024-04-01
Recruiting
Prediction and Intervention Effect of Rehabilitation Status for Severe Mental Disorder Patients Based on Multimodal Analysis and AI Agents
NCT06904079Severe Mental Disorder, Schizophrenia, Schizoaffective Disorder, Paranoid Psychosis
Shanghai Mental Health Center
Not applicable
82
Shanghai
2024-03-12
By invitation
Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
NCT07162467Schizophrenia
Tianjin Anding Hospital
Observational
200
Tianjin
2024-02-19
Recruiting
Establishing a Clinical Database and Biobank for Schizophrenia๏ผšA Cohort Study
NCT06123897Schizophrenia
Central South University
Observational
2,000
Hefei, Zhengzhou, Changsha, Nanjing
2024-01-01
Recruiting
App and Body Fat Scale in the Management of Overweight Patients
NCT05866107Schizophrenia, Bipolar Disorder, Metabolic Syndrome, Overweight and Obesity
Capital Medical University
Not applicable
204
Beijing
2023-10-31
Active, closed
Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers
NCT06105151Schizophrenia
DrugVV119
Vigonvita Life Sciences
Phase 1
82
Beijing
2023-10-27
Recruiting
NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia
NCT06021197Schizophrenia
DrugNmdae
China Medical University Hospital
Phase 2
90
2023-10-12
By invitation
Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms
NCT07356765Schizophrenia, Negative Symptoms of Schizophrenia
DrugBerberine
Tianjin Anding Hospital
Not applicable
120
Tianjin
2023-09-26
Recruiting
iTBS for Increased Appetite Induced by Antipsychotics
NCT05783063Schizophrenia
Central South University
Not applicable
60
Changsha, Dali
2023-08-01
Recruiting
Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
NCT07139171Schizophrenia
Tianjin Anding Hospital
Observational
300
Tianjin
2022-11-11
Recruiting
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant Schizophrenia
NCT05240976Schizophrenia
China Medical University Hospital
Phase 2
80
2022-02-23
Recruiting
Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia
NCT05159349Schizophrenia
Shanghai Mental Health Center
Observational
1,200
Shanghai
2021-12-01
Recruiting
Combination of NMDA-enhancing and Antioxidant Treatments for Schizophrenia
NCT04959201Schizophrenia
DrugNmdae
China Medical University Hospital
Phase 2
90
2020-11-30
Recruiting
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Schizophrenia
NCT04917302Schizophrenia
DrugNmdae
China Medical University Hospital
Phase 2
60
2020-10-13
Active, closed
Ningbo Schizophrenia Cohort
NCT06370793Schizophrenia
Ningbo University
Observational
26,899
Ningbo
2018-07-01
Recruiting
Monotherapy of an NMDA Enhancer for Schizophrenia
NCT04745143Schizophrenia
China Medical University Hospital
Phase 2
80
2018-01-01
Recruiting
An Observational Study on Atypical Antipsychotics Long-term Treatment Patients With Schizophrenia
NCT02640911Schizophrenia
Shanghai Mental Health Center
Observational
3,000
Shanghai
2010-11
Rows per page Showing 1–44 of 44
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/schizophrenia

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 44 of those studies listing the condition Schizophrenia.

How many Schizophrenia trials are recruiting in China?

30 of the 44 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 9 have not yet opened recruitment, 3 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Schizophrenia), 44 studies
PhaseStudiesRecruitingShare
Not applicable161136.4%
Observational11825%
Phase 210822.7%
Phase 1429.1%
Phase 1/2102.3%
Phase 3112.3%
Phase 4102.3%

Most active sponsors

Lead sponsors with the most studies (Schizophrenia)
Lead sponsorStudiesRecruiting
Shanghai Mental Health Center87
Central South University76
China Medical University Hospital77
Luye Pharma Group Ltd.31
Tianjin Anding Hospital31
Vigonvita Life Sciences31
Second Xiangya Hospital of Central South University20
Anhui Medical University11
Capital Medical University11
Chinese University of Hong Kong10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.